Kato Takanobu

カトウタカノブ | Kato Takanobu

Affiliation and department：
Job title：室長

Research field (1)： Virology

Research theme for competitive and other funds (14)：

2022 - 2026 Why genotype C HBV causes liver cancer more rapidly than other genotypes?
2022 - 2025 抗菌ペプトイドを用いた新規B型肝炎治療薬の開発
2019 - 2023 B型肝炎ウイルスのコア領域の変異がウイルスのライフサイクルに与える影響の解析
2015 - 2019 Evaluation of HBsAg-associated hepatocarcinogenesis
2012 - 2015 Amino Acid Polymorphism in HCHV Core Affects Infectious Virus Production and MHC Class I Molecule Expression

Show all

Papers (156)：

Shogo Nakajima, Koichi Watashi, Takanobu Kato, Masamichi Muramatsu, Takaji Wakita, Noriko Tamura, Shin-Ichiro Hattori, Kenji Maeda, Hiroaki Mitsuya, Yoshiaki Yasutake, et al. Correction for Nakajima et al., "Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V Mutations". Journal of virology. 2024. 98. 3. e0182323
Asako Murayama, Hitomi Igarashi, Norie Yamada, Hussein Hassan Aly, Natalia Molchanova, Jennifer S Lin, Hironori Nishitsuji, Kunitada Shimotohno, Masamichi Muramatsu, Annelise E Barron, et al. Antiviral effect of peptoids on hepatitis B virus infection in cell culture. Antiviral research. 2024. 223. 105821-105821
Haruka Momose, Asako Murayama, Norie Yamada, Keiji Matsubayashi, Sahoko Matsuoka, Emi Ikebe, Madoka Kuramitsu, Masamichi Muramatsu, Takanobu Kato, Isao Hamaguchi. Performance evaluation of in vitro diagnostic kits for hepatitis B virus infection using the regional reference panel of Japan. Virology Journal. 2023. 20. 1. 93-93
Xiaofang Li, Kenji Nakashima, Masahiko Ito, Mami Matsuda, Takeshi Chida, Kazumasa Sekihara, Hirotaka Takahashi, Takanobu Kato, Tatsuya Sawasaki, Tetsuro Suzuki. SRPKIN-1 as an inhibitor against hepatitis B virus blocking the viral particle formation and the early step of the viral infection. Antiviral research. 2023. 220. 105756-105756
Keigo Yato, Mami Matsuda, Kento Fukano, Tomohisa Tanaka, Kohji Moriishi, Hironori Nishitsuji, Kunitada Shimotohno, Koji Tamura, Takaji Wakita, Masamichi Muramatsu, et al. Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus. Virus research. 2023. 323. 199014-199014

ｍore...

MISC (260)：

加藤孝宣, 明里宏文. 肝炎ウイルスとワクチン-Hepatitis viruses and vaccines. 臨床免疫・アレルギー科 = Clinical immunology & allergology / 臨床免疫・アレルギー科編集委員会編. 2023. 79. 5. 564-570
加藤孝宣, 村山麻子, 村松正道. ウイルス肝炎制御(基礎・臨床)の未来予想図ワクチンエスケープ変異株に有効なLarge-HBs抗原を用いた新規HBワクチンの開発. 肝臓. 2023. 64. Suppl.1. A118-A118
山田典栄, 鈴木通博, 安田清美, 村松正道, 加藤孝宣. TAF反応不良例における次世代シーケンスを用いた薬剤耐性変異の解析. 肝臓. 2023. 64. Suppl.1. A353-A353
AlyIbrahim HusseinHassan, 加藤孝宣, 茶山一彰, 脇田隆字. Oxaprozine analogue S169はin vitroでHBV感染を有意に抑制する(Oxaprozine analogue S169 significantly suppress HBV infection in vitro). 肝臓. 2023. 64. Suppl.1. A470-A470
加藤孝宣, 明里宏文. B型肝炎ワクチン-Neutralization of hepatitis B virus with vaccine-escape mutations by novel hepatitis B vaccine with large-HBs antigen. ウイルス = Virus / 日本ウィルス学会編. 2022. 72. 2. 149-158

ｍore...

Patents (11)：

ｍore...

Professional career (1)：

医学博士

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page